Rate My Professor Huiling Wu

Wu's research investigates the roles of innate immune pathways, including Toll-like receptors (TLR4), HMGB1, and IL-18, in kidney ischemia/reperfusion injury, diabetic nephropathy, and allograft rejection. Notable publications include 'TLR4 activation mediates kidney ischemia/reperfusion injury' (2007, The Journal of Clinical Investigation), 'HMGB1 contributes to kidney ischemia reperfusion injury' (2010, Journal of the American Society of Nephrology), 'Therapeutic inflammatory monocyte modulation using immune-modifying microparticles' (2014, Science Translational Medicine), 'IL-18 contributes to renal damage after ischemia-reperfusion' (2008, Journal of the American Society of Nephrology), 'Dietary fiber protects against diabetic nephropathy through short-chain fatty acid–mediated activation of G protein–coupled receptors GPR43 and GPR109A' (2020, Journal of the American Society of Nephrology), 'The role of macrophages in allograft rejection' (2005, Transplantation), and 'Short-chain fatty acids directly exert anti-inflammatory responses in lipopolysaccharide-stimulated renal tubular epithelial cells' (2023, Frontiers in Cell and Developmental Biology). Her studies also cover DNA vaccination strategies for chemokine modulation in renal transplants, the gut-kidney axis, and dietary interventions like inulin for enhancing vaccine responses in kidney transplant recipients. Collaborating with researchers such as Stephen J. Chadban and Usha Panchapakesan, Wu has advanced understanding of inflammatory monocytes, podocyte injury, and proximal tubule inflammation in renal pathology.